Trials / Completed
CompletedNCT00354029
Effect of Perioperative i.v. Low-dose S(+) Ketamine
Effect of Perioperative i.v. Low-dose S(+) Ketamine in Patients Undergoing Hemorrhoidectomy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 83 (actual)
- Sponsor
- Asker & Baerum Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether the use of perioperative intravenous S (+) ketamine reduces the amount and degree of postoperative pain. Furthermore the purpose of this study is to determine whether the use of perioperative intravenous S (+) ketamine effects cognitive function in the early postoperative period.
Detailed description
The mechanism of development of postoperative pain is complex. Central and peripheral sensitization are playing an important role and this can lead to postoperative hypersensitization. Several studies have shown, that S (+) ketamine can be effective to reduce sensitization and postoperative pain. Ketamine (2-O-chlorophenyl-2-methylamino cyclohexanone) is a N-Methyl-D-Aspartat (NMDA) receptor antagonist. S (+) ketamine has a four times stronger affinity to the NMDA receptor compared to R (-) ketamine. The duration of action for S (+) ketamine is shorter than R (-) ketamine and it has fewer side-effects. The purpose of this study is to compare the analgetic effect of pregabalin and placebo used in the perioperative period. The hypothesis is that perioperative intravenous S (+) ketamine gives significant better analgesia than placebo without effecting cognitive function. The study is including patients undergoing hemorrhoidectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | S (+) Ketamine | 0,35 mg/kg bolus after induction of anaesthesia; 5 ug/kg/min. continuous until the end of surgery |
| DRUG | Placebo | isotonic saline |
Timeline
- Start date
- 2006-08-01
- Primary completion
- 2008-06-01
- Completion
- 2009-05-01
- First posted
- 2006-07-19
- Last updated
- 2011-07-20
- Results posted
- 2011-07-20
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT00354029. Inclusion in this directory is not an endorsement.